Evidence map›Paper›PMID 33692334›Full record

ArticleCell death & disease2021

HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis.

DongWei Liu, FengXun Liu, ZhengYong Li, ShaoKang Pan, JunWei Xie, ZiHao Zhao, ZhenJie Liu, JiaHui Zhang, ZhangSuo Liu

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Research progress on small extracellular vesicles in diabetic nephropathy.Frontiers in cell and developmental biology · 2025
    Review
  13. Exosome miRNA sorting controlled by RNA-binding protein-motif interactions.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  14. Article
  15. Urinary exosomes as promising biomarkers for early kidney disease detection.American journal of clinical and experimental urology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

DongWei Liu *Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
FengXun Liu *Department of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
ZhengYong LiDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
ShaoKang PanDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
JunWei XieDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
ZiHao ZhaoDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
ZhenJie LiuDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
JiaHui ZhangDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
ZhangSuo LiuDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China. zhangsuoliu@zzu.edu.cn.
National Clinical Research Center for Digestive Diseases · CNZhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNHenan Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is a serious complication in type 1 and type 2 diabetes, and renal interstitial fibrosis plays a key role in DN progression. Here, we aimed to probe into the role and potential mechanism of miR-483-5p in DN-induced renal interstitial fibrosis. In this study, we corroborated that miR-483-5p expression was lessened in type 1 and type 2 diabetic mice kidney tissues and high glucose (HG)-stimulated tubular epithelial cells (TECs), and raised in the exosomes derived from renal tissues in type 1 and type 2 diabetic mice. miR-483-5p restrained the expressions of fibrosis-related genes in vitro and renal interstitial fibrosis in vivo. Mechanistically, miR-483-5p bound both TIMP2 and MAPK1, and TIMP2 and MAPK1 were bound up with the regulation of miR-483-5p on renal TECs under HG conditions. Importantly, HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine. Our results expounded that HNRNPA1-mediated exosomal sorting transported cellular miR-483-5p out of TECs into the urine, thus lessening the restraint of cellular miR-483-5p on MAPK1 and TIMP2 mRNAs, and ultimately boosting extracellular matrix deposition and the progression of DN-induced renal interstitial fibrosis.

Indexed as

AnimalsBlood GlucoseCell LineDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic NephropathiesDisease ProgressionEpithelial CellsExosomesFibrosisGene Expression RegulationHeterogeneous Nuclear Ribonucleoprotein A1HumansKidney TubulesMaleBlood GlucoseHeterogeneous Nuclear Ribonucleoprotein A1Hnrnpa1 protein, mouseMapk1 protein, mouseMicroRNAsMirn483 microRNA, mouseMitogen-Activated Protein Kinase 1Timp2 protein, mouseTissue Inhibitor of Metalloproteinase-2

Identifiers

PMID33692334
PMCPMC7946926
OpenAlexW3133797810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.